Deferred Tax Assets, Valuation Allowance of REGENXBIO Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
REGENXBIO Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • REGENXBIO Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $374,413,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

REGENXBIO Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $374,413,000 +$36,061,000 +11% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q4 2024 $338,352,000 +$57,897,000 +21% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q4 2023 $280,455,000 +$69,305,000 +33% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $211,150,000 +$100,394,000 +91% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q4 2021 $110,756,000 -$32,151,000 -22% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $142,907,000 +$45,396,000 +47% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $97,511,000 +$45,978,000 +89% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q4 2018 $51,533,000 -$14,136,000 -22% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q4 2017 $65,669,000 +$25,585,000 +64% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q4 2016 $40,084,000 +$27,991,000 +231% 31 Dec 2016 10-K 06 Mar 2018 2017 FY
Q4 2015 $12,093,000 +$9,738,000 +414% 31 Dec 2015 10-K 07 Mar 2017 2016 FY
Q4 2014 $2,355,000 31 Dec 2014 10-K 03 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.